Trial Profile
Safety and Efficacy of Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy: a Single-arm, Phase 3 Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2019
Price :
$35
*
At a glance
- Drugs Icotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Sponsors Betta Pharmaceuticals Co Ltd
- 03 Jul 2015 New trial record